Peapod Lane Capital LLC Ikena Oncology, Inc. Transaction History
Peapod Lane Capital LLC
- $101 Billion
- Q4 2024
A detailed history of Peapod Lane Capital LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 507,868 shares of IKNA stock, worth $761,802. This represents 0.83% of its overall portfolio holdings.
Number of Shares
507,868Holding current value
$761,802% of portfolio
0.83%Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
61Shares Held
30.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$7.53 Million1.07% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$7.15 Million0.26% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$6.14 Million2.33% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.31 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.37 Million5.77% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $54.4M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...